ReviewRSC advances2025
Exploring the frontiers of emerging sensing of silver nanoprisms: recent progress and challenges.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Magnetic reduced graphene oxide aerogel decorated silver nanoparticles towards efficient recognition of doxorubicin in patients' blood plasma.Scientific reports · 2025Article
- Photochemical synthesis of silver nanoprisms via green LED irradiation and evaluation of SERS activity.Beilstein journal of nanotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the development and use of nanomaterials have transformed numerous aspects of biomedical science. Nanomaterials have played a pivotal role in advancing disease diagnosis and treatment across a wide range of applications. Within this scope, silver nanoprisms (AgNPrs) stand out due to their remarkable properties, such as extensive surface area, chemical robustness, and tunable electrical conductivity, making them excellent candidates for biomedical purposes. By tailoring these nanomaterials through functionalization or coating surface, their multifunctionality can be enhanced, unlocking new opportunities for their application in areas such as diagnosis, imaging, and therapeutic intervention. This review begins with an overview of AgNPrs' synthesis techniques and their unique physicochemical characteristics. Recent advancements in analytical methods utilizing AgNPrs, categorized by sensing mechanisms such as optical and electrochemical approaches, are highlighted in the context of diagnostics. Lastly, the challenges and future prospects of bringing AgNPr-based technologies to commercialization and integrating them into disease diagnostics and medical treatment are explored. The integration of AgNPrs in disease therapy holds promise for the development of advanced chemotherapy agents that effectively address the challenges of efficient cancer treatment looking ahead, the ongoing advancement of nanocarrier systems comprising AgNPrs-based molecules holds great promise for improving the quality of life for patients worldwide.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.